GLP-1 Meds and Breastfeeding Study
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests whether a type of diabetes/weight loss medication (GLP-1 RA, given as a shot) affects milk production in breastfeeding mothers. It may help women who need this medicine while nursing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a breastfeeding mother of one or more babies.
- You pump or nurse at least 4 times a day.
- You are eligible to receive a GLP-1 RA as a shot (not a pill).
- You have access to a breast pump if needed.
- You are willing to give 1–3 ounces of breastmilk at each study visit.
- You are willing to weigh yourself daily and keep breastfeeding for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a type of weight-loss medication called GLP-1 affects pregnancy and baby outcomes. It aims to learn if this medication is safe to use early in pregnancy.
This study follows people who recently stopped taking a GLP-1 medication to see how their eating habits, daily routines, and weight change over time. It aims to learn how to better support people after they stop, helping them maintain a healthy weight.
This study looks at how your body composition (muscle and fat) changes after you start a GLP-1 medication for obesity or type 2 diabetes. You will be followed for a year with body scans to see the effects.
This study looks at how GLP-1 receptor agonist drugs (used for weight loss) affect muscle mass and strength in people with obesity who do not have diabetes. It may help understand if these medications impact muscle health.
This trial tests if a GLP-1 receptor agonist can help people with multiple sclerosis who have a high BMI. It may reduce inflammation and improve health.
This study is for people who have lost weight using GLP-1 injections (like semaglutide or tirzepatide) and are thinking about stopping them. It tests whether switching to an oral weight-loss medication can help you keep the weight off.
Hear when a new Weight Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.